(Q39353700)

English

Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study

scientific article published on April 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

prostatic hypertrophy

1 reference

based on heuristic

inferred from title

author name string

Yoshinori Nishino

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Takako Masue

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Kousei Miwa

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Yoshito Takahashi

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Satoshi Ishihara

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Takashi Deguchi

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

publication date

1 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

BJU International

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

97

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

747-51, discussion 751

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06030.X

21 January 2018

Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06030.X

21 January 2018

Quantification and distribution of alpha 1-adrenoceptor subtype mRNAs in human prostate: comparison of benign hypertrophied tissue and non-hypertrophied tissue

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06030.X

21 January 2018

Alpha1-adrenergic receptors in human spinal cord: specific localized expression of mRNA encoding alpha1-adrenergic receptor subtypes at four distinct levels.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06030.X

21 January 2018

Modulation of bladder alpha1-adrenergic receptor subtype expression by bladder outlet obstruction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06030.X

21 January 2018

Increased contractile response to phenylephrine in detrusor of patients with bladder outlet obstruction: effect of the alpha1A and alpha1D-adrenergic receptor antagonist tamsulosin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06030.X

21 January 2018

Effects of intrathecal injection of tamsulosin and naftopidil, alpha-1A and -1D adrenergic receptor antagonists, on bladder activity in rats.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06030.X

21 January 2018

How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06030.X

21 January 2018

Management of overactive bladder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06030.X

21 January 2018

Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06030.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2006.06030.X

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39353700&oldid=1822793009"